BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 29, 2016
View Archived Issues
Hookipa Biotech initiates first-in-human study of HB-101 vaccine for CMV
Read More
Bacillus anthracis capsule conjugate vaccine protects rhesus macaques against inhalational anthrax
Read More
Ad-hoc analysis of phase I/II data for lentiviral hemopoietic stem-cell gene therapy
Read More
RE-024 shows promise for the treatment of PKAN
Read More
New radiological tracer developed for prostate cancer imaging
Read More
FDA advisory committee recommends approval of Jardiance in cardiovascular indication
Read More
FDA approves Epclusa as pan-genotypic single-tablet regimen for chronic HCV infection
Read More
Encouraging results for hNSC transplantation to treat SCI
Read More
Celyad reports headline results from CHART-1 phase III study of C-Cure
Read More
XOMA starts XOMA-123 phase II study
Read More
FDA grants fast track designation to arimoclomol for Niemann-Pick disease type C
Read More
Cempra submits solithromycin MAA to EMA
Read More
Novel PET radioligand shows promise for measuring brain microglial COX-1
Read More
Ablynx to license FOX technology for study of inhaled anti-RSV nanobody
Read More
Bio-Path and Thomas Jefferson University sign agreement
Read More
AbbVie ends duvelisib collaboration with Infinity Pharmaceuticals
Read More
Anthera updates progress of blisibimod and liprotamase programs
Read More
Intra-Cellular Therapies begins phase III trial of ITI-007
Read More
OmniSeq receives New York CLEP approval for OmniSeq Comprehensive panel
Read More
EMA committee recommends granting orphan drug designation to Vicore's C-21 in IPF
Read More
European commission grants orphan medicinal product designation to Ultragenyx's burosumab
Read More
Two phase III studies of Pfizer's bococizumab meet primary endpoints
Read More
